Thrive Capital Management, LLC Sanofi Transaction History

Thrive Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$43.13 - $54.79 $94,540 - $120,099	-2,192 Reduced 29.75%	5,176 $257,000
Q3 2023 Nov 02, 2023	SELL	$50.95 - $55.2 $815 - $883	-16 Reduced 0.22%	7,368 $395,000
Q2 2023 Aug 02, 2023	BUY	$50.45 - $57.18 $97,973 - $111,043	1,942 Added 35.69%	7,384 $397,000
Q1 2023 May 08, 2023	BUY	$45.86 - $54.45 $249,570 - $296,316	5,442 New	5,442 $296,000
Q1 2022 May 06, 2022	SELL	$48.48 - $53.65 $458,814 - $507,743	-9,464 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$47.07 - $52.35 $398,400 - $443,090	-8,464 Reduced 47.21%	9,464 $474,000
Q3 2021 Nov 12, 2021	BUY	$47.89 - $53.12 $103,298 - $114,579	2,157 Added 13.68%	17,928 $864,000
Q2 2021 Aug 06, 2021	BUY	$49.36 - $54.25 $268,962 - $295,608	5,449 Added 52.79%	15,771 $831,000
Q1 2021 May 10, 2021	BUY	$45.46 - $50.51 $130,652 - $145,165	2,874 Added 38.59%	10,322 $511,000
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $337,394 - $384,465	7,448 New	7,448 $362,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Thrive Capital Management, LLC with notifications on news.